Orbimed Advisors Trims $125 After Breakout Year in Biotech
A major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
Indices fluctuate due to price swings in components and shifting sentiment. This short intro outlines the main causes of index volatility.
22,408 articlesA major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
When an executive at Century Aluminum sells millions in stock, investors take notice. This article breaks down what t...
Apple’s stock has climbed 108% over five years, signaling a rare blend of device strength, services expansion, and ca...
Cloudflare's first-quarter 2026 results set the stage for a dynamic year. This analysis breaks down what worked, what...
NIO reports its first-ever quarterly profit, but shares fall while Tesla leads a modest rally, illustrating the two-s...
Amgen has navigated headwinds to chart a path toward renewed growth. This analysis breaks down the catalysts, risks, ...
In a landmark move, australia’s richest person just disclosed a stake worth more than $1 billion in SpaceX as the pri...
With SPY's yield hovering near 1% and valuations high, investors are turning to covered calls to generate cash flow. ...
As Boyd Gaming nears its July 23 earnings, traders are weighing a potential 17.2% upside fueled by a disciplined buyb...
Apple is reportedly adopting a Netflix style strategy, focusing on originals, bundling, and scalable growth. This art...
A forward-looking look at Compugen's 2025 earnings. Learn how pipeline progress, partnerships, and cash runway could ...
Dividend investing can deliver steady income even when markets swing. Here are three no-brainer dividend stocks right...